Adoptive immunotherapy with haploidentical KIR-ligand mismatched NK cells for acute myeloblastic leukemia patients

被引：0
|
作者：
Lemoli, Roberto. M. [1 ]
机构：
[1] Univ Genoa, Genoa, Italy
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2017年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O4.01
引用
下载
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [21] Impact of KIR-Ligand Mismatch on Pediatric T-Cell Acute Lymphoblastic Leukemia in Unrelated Cord Blood Transplantation
    Kawahara, Yuta
    Sato, Maho
    Kobayashi, Ryoji
    Hiwatari, Mitsuteru
    Goi, Kumiko
    Saito, Shoji
    Hashii, Yoshiko
    Kato, Koji
    Atsuta, Yoshiko
    Sakaguchi, Hirotoshi
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [22] Impact of KIR-ligand mismatch on pediatric T-cell acute lymphoblastic leukemia in unrelated cord blood transplantation
    Kawahara, Yuta
    Ishimaru, Sae
    Tanaka, Junji
    Kako, Shinichi
    Hirayama, Masahiro
    Kanaya, Minoru
    Ishida, Hisashi
    Sato, Maho
    Kobayashi, Ryoji
    Kato, Motohiro
    Goi, Kumiko
    Saito, Shoji
    Koga, Yuhki
    Hashii, Yoshiko
    Kato, Koji
    Sato, Atsushi
    Atsuta, Yoshiko
    Sakaguchi, Hirotoshi
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (09): : 598.e1 - 598.e8
  • [23] Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion
    Wei Wang
    Amy K. Erbe
    Kory A. Alderson
    Emily Phillips
    Mikayla Gallenberger
    Jacek Gan
    Dario Campana
    Jacquelyn A. Hank
    Paul M. Sondel
    Cancer Immunology, Immunotherapy, 2016, 65 : 1047 - 1059
  • [24] Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group
    Erbe, Amy K.
    Wang, Wei
    Carmichael, Lakeesha
    Kim, KyungMann
    Mendonca, Eneida A.
    Song, Yiqiang
    Hess, Dustin
    Reville, Patrick K.
    London, Wendy B.
    Naranjo, Arlene
    Hank, Jacquelyn A.
    Diccianni, Mitchell B.
    Reisfeld, Ralph A.
    Gillies, Stephen D.
    Matthay, Katherine K.
    Cohn, Susan L.
    Hogarty, Michael D.
    Maris, John M.
    Park, Julie R.
    Ozkaynak, M. Fevzi
    Gilman, Andrew L.
    Yu, Alice L.
    Sondel, Paul M.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 189 - 196
  • [25] Reduced risk of residual molecular and hematological relapse in patients with CML after KIR-ligand mismatched hematpoietic stem cell transplantation.
    Elmaagacli, AH
    Ottinger, H
    Michael, K
    Rudolf, P
    Steckel, NK
    Trenschel, R
    Biersack, H
    Grosse-Wilde, H
    Flasshove, M
    Beelen, DW
    BLOOD, 2004, 104 (11) : 279A - 279A
  • [26] Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion
    Wang, Wei
    Erbe, Amy K.
    Alderson, Kory A.
    Phillips, Emily
    Gallenberger, Mikayla
    Gan, Jacek
    Campana, Dario
    Hank, Jacquelyn A.
    Sondel, Paul M.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (09) : 1047 - 1059
  • [27] A higher CD34+cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia
    Ishida, Hisashi
    Kawahara, Yuta
    Tomizawa, Daisuke
    Okamoto, Yasuhiro
    Hama, Asahito
    Cho, Yuko
    Koh, Katsuyoshi
    Koga, Yuhki
    Yoshida, Nao
    Sato, Maho
    Terui, Kiminori
    Miyagawa, Naoyuki
    Watanabe, Akihiro
    Takita, Junko
    Kobayashi, Ryoji
    Yamamoto, Masaki
    Watanabe, Kenichiro
    Okada, Keiko
    Kato, Koji
    Matsumoto, Kimikazu
    Hino, Moeko
    Tabuchi, Ken
    Sakaguchi, Hirotoshi
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [28] Expansion of Donor NK Cells for Adoptive Immunotherapy in Haploidentical Stem Cell Transplantation: A Phase I-II Study
    Siegler, Uwe
    Meyer-Monard, Sandrine
    Joerger, Simon
    Stern, Martin
    Tichelli, Andre
    Gratwohl, Alois
    Wodnar-Filipowicz, Aleksandra
    Kalberer, Christian
    BLOOD, 2008, 112 (11) : 1327 - 1327
  • [29] NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs
    Ichise, Hiroshi
    Nagano, Seiji
    Maeda, Takuya
    Miyazaki, Masaki
    Miyazaki, Yuki
    Kojima, Hiroto
    Yawata, Nobuyo
    Yawata, Makoto
    Tanaka, Hidenori
    Saji, Hiroh
    Masuda, Kyoko
    Kawamoto, Hiroshi
    STEM CELL REPORTS, 2017, 9 (03): : 853 - 867
  • [30] CELL-MEDIATED CYTOTOXICITY (CMC) IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA RECEIVING IMMUNOTHERAPY
    TAYLOR, GM
    HARRIS, R
    FREEMAN, CB
    BRITISH JOURNAL OF CANCER, 1975, 32 (02) : 242 - 242
12345